FdaApplication
ANDA 213040
Identifiers
- fda_app_no: ANDA213040
Properties
| Property | Value |
|---|---|
| applicant_name | AUROLIFE PHARMA LLC |
| application_type | ANDA |
| approval_date | 2023-02-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | 2% | SOLUTION;TOPICAL |
1 product